Status:
COMPLETED
Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection
Lead Sponsor:
Novartis
Conditions:
Herpes Simplex
Eligibility:
All Genders
1-1 years
Phase:
PHASE2
Brief Summary
This study will evaluate the acceptability and safety of famciclovir in infants with herpes simplex infection
Eligibility Criteria
Inclusion
- Male and female patients from 1 month up to 1 year of age with herpes simplex infection
Exclusion
- Patients with gestational age less than 32 weeks. Patients unable to swallow. Patients with history of malabsorption or previous gastrointestinal surgery.
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00448227
Start Date
October 1 2007
Last Update
February 11 2011
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Infectious Disease Of University of Alabama
Birmingham, Alabama, United States
2
Children's Memorial Hospital Chicago
Chicago, Illinois, United States
3
Children's Hospital of Michigan
Detroit, Michigan, United States
4
Archana Chatterjee
Omaha, Nebraska, United States, 68131